All-atom molecular dynamics simulation of Cyclophilin A in complex with Sanglifehrin A
Authors:
Open Access
- 22 September 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (9) , e0358847
Abstract
Cyclophilin A (CypA), a key peptidyl-prolyl cis/trans isomerase, plays a pivotal role in various biological processes and is a target for therapeutic intervention, particularly in viral and cancer-related diseases. This study explores the structural and dynamic effects of Sanglifehrin A (SangfA), a potent CypA inhibitor, using molecular dynamics (MD) simulation. All-atom MD simulations (100 ns) of apo CypA and its complex with SangfA were performed using GROMACS v2023. In addition to MD analyses, essential dynamics, clustering, secondary structure, and binding free energy were analyzed. SangfA binding induces a dual dynamic response: local rigidification of the active-site β2-β3 loop, residues 100–102 and 108–111 with a coil‑to‑β-strand transition (β-sheet content rises from 28.0% to 32.3%), alongside enhanced mobility in distal loops and a 1.1‑fold expansion of the conformational ensemble. Principal component analysis shows redistribution of motions from a single dominant mode (apo PC1 = 44.2%) to more diffuse fluctuations (holo PC1 = 30.4%), increasing configurational entropy. The ligand forms a dynamic hydrogen‑bond network (1–2 persistent bonds) anchored by Arg55 and hydrophobic contacts with Phe60 and Lys105, while Arg55 remains uninvolved. The computed binding free energy (ΔG = −20.45 ± 3.07 Kcal/mol) accords with picomolar potency. SangfA acts via conformational selection, stabilizing a pre‑existing CypA substate with augmented β-structure and broader dynamics. This entropically driven mechanism challenges static inhibition paradigms. Future efforts should validate the β2-β3 loop transition experimentally and exploit the Lys105 contact to design next‑generation cyclophilin inhibitors.Keywords
All Related Versions
This publication has 67 references indexed in Scilit:
- Molecular dynamics simulations of proteins: an in-depth review of computational strategies, structural insights, and their role in medicinal chemistry and drug developmentBiological Cybernetics, 2025
- Characterization, Antibacterial Evaluation and Computational Study of Synthesized 4,5‐bis(Hydroxymethyl)‐2‐Methylpyridin‐3‐ol Tetraphenylborate Ion‐Pair ComplexChemistryOpen, 2025
- Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infectionHepatology, 2015
- Optimization of parameters for molecular dynamics simulation using smooth particle‐mesh Ewald in GROMACS 4.5Journal of Computational Chemistry, 2011
- A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6Journal of Computational Chemistry, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Molecular dynamics of biological macromolecules: A brief history and perspectiveBiopolymers, 2003
- X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997
- Interaction Models for Water in Relation to Protein Hydration1981